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Abstract
Background: Home Management of Malaria (HMM) is one of the key strategies to reduce the burden of malaria for vulnerable
population in endemic countries. It is based on the evidence that well-trained communities health workers can provide prompt
and adequate care to patients close to their homes. The strategy has been shown to reduce malaria mortality and severe
morbidity and has been adopted by the World Health Organization as a cornerstone of malaria control in Africa. However, the
potential fall-out of this community-based strategy on the work burden at the peripheral health facilities level has never been
investigated.
Methods: A two-arm interventional study was conducted in a rural health district of Burkina Faso. The HMM strategy has been
implemented in seven community clinics catchment's area (intervention arm). For the other seven community clinics in the
control arm, no HMM intervention was implemented. In each of the study arms, presumptive treatment was provided for
episodes of fevers/malaria (defined operationally as malaria).
The study drug was artemether-lumefantrine, which was sold at a subsidized price by community health workers/Key opinion
leaders at the community level and by the pharmacists at the health facility level.
The outcome measured was the proportion of malaria cases among all health facility attendance (all causes diseases) in both
arms throughout the high transmission season.
Results: A total of 7,621 children were enrolled in the intervention arm and 7,605 in the control arm. During the study period,
the proportions of malaria cases among all health facility attendance (all causes diseases) were 21.0%, (445/2,111, 95% CI [19.3%–
22.7%]) and 70.7% (2,595/3,671, 95% CI 68.5%–71.5%), respectively in the intervention and control arms (p << 0.0001). The
relative risk ratio for a fever/malaria episode to be treated at the HF level was 30% (0.30 < RR < 0.32).
The number of malaria episodes treated in the intervention arm was much higher than in the control arm (6,661 vs. 2,595), with
malaria accounting for 87.4% of all disease episodes recorded in the intervention area and for 34.1% in the control area (P <
0.0001). Of all the malaria cases treated in the intervention arm, only 6.7% were treated at the health facility level.
Conclusion:  These findings suggest that implementation of HMM, by reducing the workload in health facilities, might
contributes to an overall increase of the performance of the peripheral health facilities.
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Background
Malaria remains the leading cause of child mortality and
morbidity in sub-Saharan Africa [1-3]. High malaria trans-
mission intensity, limited access to adequate treatment,
increasing parasite resistance to affordable and safe medi-
cines (chloroquine, sulphadoxine-pyrimethamine and
amodiaquine); increasing vectors resistance to widely
used insecticides, delayed care-seeking and inappropriate
treatment at home or at community level, are some of the
causes for this deleterious situation.
In 2000, the African Heads of State adopted the access to
prompt and effective treatment for at least 60% of those
suffering from malaria as one of the goal in reducing the
malaria burden for the vulnerable population in Africa
[4]. This goal in the context of the limited coverage of the
population by health facilities in most of the malaria
endemic countries seems quite ambitious and difficult to
achieve. Therefore, the Home Management of Malaria
(HMM) strategy that has been developed to provide
prompt and effective treatment of malaria episodes to
those who need it close to their homes represents one of
the major strategies that could contribute to achieve this
goal [5].
The Roll Back Malaria (RBM) initiative has defined the
HMM as an integral part of an overall malaria case man-
agement strategy aiming to improve access to treatment
for malaria in areas with limited access to health facilities.
The strategy aims to improve the ineffective self-medica-
tion practices that are very common in malaria-endemic
countries; its overall goal is the early recognition and
prompt and appropriate response to malarial illness,
especially in children under five years of age, in the home
or community. It, therefore, empowers communities to
respond to malaria illness using effective, good-quality
antimalarial medicines through community involvement
[5].
Several studies conducted under the leadership of the
World Health Organization, have demonstrated its feasi-
bility and efficacy [6-8]. In recent years, with the almost
universal development of CQ resistance [9-11], HMM is
being promoted with artemisinin-based combination
therapy (ACT). Despite some concerns on the widespread
use of such drugs at community level [12] recent data have
shown that ACT can be used safely within the context of
the HMM strategy [13,14].
In Burkina Faso, the HMM strategy has been adopted by
the National Malaria Control Programme in an effort to
reach the Abuja target. Unfortunately, artemether-lume-
fantrine (AL)(Coartem®), which is to be used at the com-
munity level in the context of this strategy, is not yet
available in the public sector; the implementation of the
strategy is, therefore, facing some delays.
During the high transmission season of malaria, epi-
sodes of fever/malaria (from now on operationally
defined as 'malaria') in children, account for more than
1/3 of the attendances at first level health facilities. A
limited number of health personnel in peripheral health
facilities named Centre de Santé et de Promotion Social
(CSPS) (usually no more than three staff members
including two nurses and one midwife) are assigned to
perform a minimal package of activities, including ante-
natal care services, out-patient management, Expanded
Programme of Immunization (EPI), counselling, admin-
istrative tasks etc. This results in a very high workload
with a potential negative impact on the quality of the
services provided.
This study has evaluated the effect of the case manage-
ment of malaria at a more peripheral level than the health
facility – in the community within the context of HMM –
on the workload of the health staff operating in first level
health facilities.
Methods
The study was an interventional study, conducted in the
rural health district of Saponé located at around 45 km
south of Ouagadougou, the capital of Burkina Faso. The
climate in the area is characteristic of the Sudanese savan-
nah, with a dry season from November to May and a rainy
season from June to October. Malaria transmission is
markedly seasonal, with most transmission occurring dur-
ing the rainy season with an entomological inoculation
rate ranging from 50–200 infective bites/person/year.
Plasmodium falciparum is the most predominant malaria
parasite accounting for more than 95% of infections in
children less than five years of age. Malaria burden is
heaviest among children aged less than 5 years, with every
child experiencing an average of two clinical malaria epi-
sodes every transmission season.
The health district area covers fourteen community clinics
(CSPS), which represent the first level of care in the health
system of Burkina Faso. The mean area covered by the
catchment area of each CSPS is 9.7 km2. Thus, the popu-
lation has access to the CSPS within an average walking
distance of 10 km.
There is no private practice of medicine and drugs selling
in the area. Population has legally access to treatment
drugs (exclusively generics) including antimalarial drugs
through the drug store located in these community clinics;
however, there is a parallel market where many other ille-
gally imported drugs are sold.
The study was not randomized. The fourteen community
clinics were equally assigned to one of the study arms:
seven in the intervention arm and seven in the control
arm. Prior to any activity, discussion was conducted withMalaria Journal 2008, 7:201 http://www.malariajournal.com/content/7/1/201
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the communities to inform them about the research and
seek their assent to participate.
A baseline general census was afterward conducted in
both arms to determine the population size, with main
focus on the target population for the intervention (chil-
dren less than five years of age). A health care-seeking
behaviour study was conducted to identify, at baseline,
whether the two study arms were comparable in regard of
this aspect.
Following these baseline activities, in the intervention
arm, Community Health Workers (CHWs) and Key Opin-
ion Leaders (KOLs) were identified by their respective
communities and trained by the study team to recognize
the symptoms of uncomplicated malaria and provide the
study treatment, which was artemether-lumefantrine
(AL)(Coartem®). AL was pre-packaged in two different
blister packs by the manufacturer for children aged
between 6–35 months (yellow blister pack) and 36–60
months (blue blister pack). CHWs/KOLs were also trained
in recognition of symptoms of severity of malaria (pros-
tration, coma, convulsions), as well as other childhood
non-malaria diseases, such as pneumonia (cough with
fast breathing) or acute diarrhoea, which require immedi-
ate referral to the nearest health facility.
In terms of role and responsibilities, while the CHWs and
the KOLs were both sharing the responsibility of provid-
ing treatment to the sick children, the CHW was playing
the additional role of local suppliers of the study drugs to
a certain number of KOLs under his/her responsibility.
They were responsible for getting the study drugs at the
health facility drug store, for their own stock renewal and
for supplying the KOLs under their coverage. Thus, CHWs
were acting as the link between the local health facility
and the KOLs in terms of study drugs supply chain.
The nurses and the drug-store keepers at the health facility
have assisted the study team in the training of the CHWs/
KOLs. The training has included 189 CHWs/KOLs in the
intervention arm. For both arms, 30 nurses (15 in each
arm) and 14 drug-stores keepers (7 in each arm) were
trained. A post-training survey was conducted to assess
CHWs/KOLs knowledge, attitude and practices in order to
identify any need of retraining before the study start. An
oral interview was conducted with a sample of 40 CHWs
and 127 KOLs, of which 56 males (33.5%) and 111
females (66.5%). A questionnaire was used.
The mean age was 33.5 years (range 16 to 60). The major-
ity were farmers (98.8%).
Most of the CHWs/KOLs were able to recognize the
malaria symptoms (Table 1). In particular, the main
symptom (hot body) was mentioned by the totality of the
interviewees.
The knowledge of the CHWs/KOLs on the requirements
for the study drug prescription was also assessed taking
the example of the case of a five-months old child; a
wrong prescription was noted for 8 CHWs/KOLs (4.2%);
the study drug was not indicated for the majority.
Criteria of severity like pallor, fast breathing and convul-
sions warranting urgent referral were also mentioned by
all the workers. At the end of the evaluation session, the
need of refresher training on the study drugs prescription
was identified. All the CHWs/KOLs benefited from this
training.
Table 1: Baseline characteristics
Intervention arm
(N = 1021)
Control arm
(N = 1034)
P
Mean age of the caregivers (mean ± SD; range) 24.3 ± 6.3 (17; 52) 23.6 ± 5.8 (18; 45) 0.14
Number of children less than five years (mean ± SD; range) 1.5 ± 0.01
(1; 3)
1.4 ± 0.01
(1; 3)
0.21
Knowledge of malaria transmission
Mosquitoes 282 (27.6%) 291 (28.1%) 0.79
Others (rain, sun) 138 (13.5%) 112 (10.8%) 0.06
Health care-seeking behaviour (first option for treating malaria episodes)
Use of health facility 289 (28.3%) 278 (26.9%) 0.45
Self-treatment 732 (71.7%) 758 (73.3%) 0.45
Children malaria symptoms mentioned by the caregivers
Hot body 748 (73.3%) 752 (72.7%) 0.78
Crying more than usual 161 (15.8%) 186 (18.0%) 0.18
Yellowish vomiting 358 (35.1%) 385 (37.2%) 0.30
Anorexia 229 (22.4%) 190 (18.4%) 0.02
Others 39 (3.8%) 43 (4.2%) 0.69Malaria Journal 2008, 7:201 http://www.malariajournal.com/content/7/1/201
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A study drug (AL) distribution channel was set up. The
study drugs were made available by the project to the dis-
trict main drug store, which supplied each community
clinic drug-store. The community clinic drug-store in turn
supplied the CHWs acting in their respective villages as
main drug-store. The KOLs in each village were supplied
by their respective CHWs. For a self-sustainability of the
distribution channel, an incentive margin of 10 FCFA
(0.024 USD) (per unit of treatment sold) was allowed at
each step of the distribution channel.
To initiate the distribution channel, each level was pro-
vided proportionally to its need with a seed stock of AL,
made available free-of-charge by the project. Final cost of
the drug for the caregivers was 100 FCFA (0.24 USD) for
the yellow blister pack and 200 FCFA (0.48 USD) for the
blue blister pack, whatever place they purchased it (at the
CHWs/KOLs level or at the community clinic drug-store
level). The standard price of Coartem® was 10 USD in the
private sector. AL was not yet available in the public sector
at the time of the study.
Despite an effort to bring down the cost of drugs in order
to improve as much as possible the financial access for the
caregivers, it was anticipated that some vulnerable groups
may not be able to afford the cost for the drugs. The CHWs
and the KOLs were instructed to deliver the drugs free-of-
charge to such groups. The cost was reimbursed to them
by the project.
To enhance accessibility of caregivers to CHWs and, there-
fore, their adherence to the strategy, a ratio of one CHW/
KOL per 40 children was adopted. Taking into account the
population density of the study area, this ratio offers the
advantage that any sick child will be living within less
than 25 minutes walk from a CHW/KOLs household.
In the control arm, there were no CHWs/KOLs at the com-
munity level. AL was made available in both arms at the
health facilities level, at the same cost as in the commu-
nity [100 Francs CFA (0.24 USD) for the yellow blister
pack and 200 Francs CFA (0.48 USD) for the blue blister
pack].
The intervention has started in May 2006 and the study
drugs were deployed in July 2006. A survey was conducted
in October 2006 (at the end of malaria high transmission
season) both at community and health facility level to
assess activities in terms of malaria cases management of
CHWs/KOLs and health centre staff.
Statistical analysis
Paper forms were used to collect the study data. The com-
pleted questionnaires were verified and data double
entered electronically and analysed using EPI-INFO (Ver-
sion 6.04) (CDC, Atlanta, USA and WHO). Standard
quality control checks were instituted to ensure the con-
sistency of the data.
The primary outcome to be measured was the number of
cases treated for malaria in both study arms. Malaria epi-
sodes were defined as the caregiver reporting to the
CHWs/KOLs or to the health facility because of his/her
child experiencing/having experienced an episode of "hot
body". No measurement of temperature or of malaria par-
asitaemia was performed. The use of a case definition
based on "hot body" is in line with the WHO HMM strat-
egy and has been previously adopted by Sirima et al [4].
From the national health statistics, malaria represent on
average 30% of all causes health facility attendance; the
minimum sample size required was, therefore, 263
malaria cases treated per study arm over the three months
period of the study to detect a reduction of at least 25%
between the intervention and the control arm (with 95%
confidence interval).
The impact of the intervention in reducing the health
facility attendance for malaria episodes in the study pop-
ulation has been calculated using the formula 1 minus the
rate ratio (relative risk). Pearson's chi test was used to
compare proportions at the significance level of P = 0.05.
Ethical clearance
The study protocol was reviewed and approved by the eth-
ics committee of the WHO and the National Ethical Com-
mittee of Burkina Faso. Appropriate authorities in the
district were informed and approval sought from them.
Community meetings were held with community leaders
in the intervention arm, to discuss with them the purpose
of the study and to obtain their adhesion.
Results
Background information
The baseline census showed a total population of 40,649
in the intervention arm and 40,557 in the control arm.
Children aged less than five years were 7,621 and 7,605
respectively. The study profile is provided is figure 1.
To check if there was any difference in health-seeking
behaviour in the two arms, a baseline survey was con-
ducted randomly in 1,021 mothers/caregivers in the inter-
vention arm and 1,034 in the control arm. The use of
health facilities for the treatment of children fevers was
declared as the first option for 28.3% and 26.9%, respec-
tively in the intervention and the control arms (p = 0.45).
In terms of clinical signs/symptoms of malaria, the hot
body was reported by most of the caregivers (73.3% in
intervention arm versus 72.7% in the control arm (p =
0.78). Other signs reported were yellowish vomiting, cry-
ing more than usual and anorexia (Table 1).Malaria Journal 2008, 7:201 http://www.malariajournal.com/content/7/1/201
Page 5 of 8
(page number not for citation purposes)
Episodes of disease (all causes) treated at health facility 
(HF) level
From August to October 2006, 2,111 episodes of disease
(all causes) in children under the age of five were treated
in HF of the intervention arm, and 3,671 in HF of the con-
trol arm; this corresponds to an incidence of disease epi-
sodes of 27.7% (2,111/7,621) and 48.3% (3,671/7605),
respectively (95% CI 26.7%–28.7% and 47.2%–49.4%).
Within each of the study arms, there was a trend to an
increase of the incidence of disease episodes over the
three-month study period (Table 2). The overall workload
in the HF of the intervention area was thus reduced by
43%, p << 0.0001.
Non-malaria diseases treated at the health facility level
have represented 29.3% in the control arm (1,076/3,671)
versus 78.9% (1,666/2,111) in the intervention arm (P <<
0.0001). (Figure 2)
Episodes of malaria treated at HF and community level
A total of 6,661 malaria cases were treated in the interven-
tion arm, where HMM was available, versus 2,595 in the
control arm, where treatment was available only at HF
level. Thus, the malaria episodes accounted for 87.4% of
all disease episodes recorded in the intervention area and
for 34.1% in the control area (P < 0.0001). Of all the
malaria cases treated in the intervention arm, only 445
(6.7%) were treated at the health facility level. Thus,
almost 90% of the malaria cases in this arm have been
treated by the CHWs/KOLs at the community level.
In general, for the population of children aged less than
five years, health facility attendance for malaria episodes
has represented 21.0% of overall HF attendance in the
intervention arm and 70.7% in the control arm (445/
2,111, 95% CI 19.3%–22.7% and 2,595/3,671, 95%CI
68.5%–71.5%, p << 0.0001) (Figure 1). This translates in
a relative risk ratio of 30% (0.30 < RR < 0.32) of a malaria
episode to be treated at HF level in the intervention arm.
The impact of the intervention in reducing the proportion
of malaria episodes of the total number of cases managed
at the health facility level was, therefore, estimated to be
70.0%.
Discussion
The outcome measurement has occurred within a rela-
tively short time period after the intervention phase of the
study (three months). This period, which corresponds to
the end of the high transmission season, when all the
players (HF, CHWs/KOLs) have gone through intense
activities, is considered as the most accurate to detect sig-
nificant impact of the intervention on the workload
imputable to malaria cases management. A similar time
window was used by Sirima et al [8]. Question on whether
the findings of this study will be observed if the outcome
measurement was done after a longer period is to be con-
sidered; however, in the context of the study area, where
the malaria transmission is highly seasonal, the HMM
The trial profile Figure 1
The trial profile.
Table 2: Incidence of the diseases episodes at the health facility level
Intervention arm (N = 7621) Control arm (N = 7605)
Months Nb. of diseases episodes Incidence Nb. of diseases episodes Incidence
nn / N 9 5 %  c i nn / N 9 5 %  c i
August 526 6.9% (6.3%–7.5%) 1009 13.3% (12.5%–14.1%)
September 575 7.5% (6.9%–8.1%) 1182 15.5% (14.7%–16.3%)
October 1010 13.3% (12.5%–14.1%) 1480 19.5% (18.6%–20.4%)
Total 2111 27.7% (26.7%–28.7%) 3671 48.3% (47.2%–49.4%)Malaria Journal 2008, 7:201 http://www.malariajournal.com/content/7/1/201
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strategy will be implemented within the same timeframes
used in this study to avoid wastage of resources and min-
imize the over-treatment of malaria during the low trans-
mission season, when prevalence of the disease is very
low. Therefore, the findings of this study could be consid-
ered as valid for areas with the same transmission pattern;
different assessment timeframe need to be implemented
in areas with a longer transmission period, to account for
the necessity to sustain the HMM strategy in order to
induce an optimum impact on the outcome measured in
this study.
The number of malaria episodes treated in the interven-
tion arm was more than double the number of cases
treated in the control arm (+156%). This shows that once
the option of treating malaria close to home is made avail-
able, caregivers make use of it and the number of malaria
episodes treated increases. No other reason can explain
this finding, as both areas have a similar epidemiological
profile and malaria transmission pattern, with compara-
ble health care-seeking behaviour, as shown in the base-
line data. The most plausible explanation is thus that the
presence of CHWs/KOLs, by increasing the access to an
effective treatment in the intervention arm, has boosted
the caregiver's willingness to use this new possibility,
reducing the use of other sources of treatment.
The presence of the CHWs/KOLs is also the possible
explanation to the fact that a significant difference was
observed between intervention and control arms in terms
of the treatment of non-malaria diseases. Indeed, while a
reduction of number of malaria cases treated at the health
facility level was observed in the intervention arm, the
proportion of non-malaria cases treated there was signifi-
cantly higher as compared to the control group.
It is possible that, at the community level, the CHWs/
KOLs have played the role of "triage staff" for the health
facilities, by treating the malaria cases and referring those
cases not considered as caused by malaria to the health
facility level. This was possible since the training module
of the CHWs/KOLs included recognition of the most prev-
alent non-malaria illnesses in the area (mainly cough with
fast breathing proxy for pneumonia, diarrhoeal diseases)
and the recommendation of immediate referral to the
health system to avoid unnecessary delay in the manage-
ment of those cases. Also, after two days of home treat-
ment, persistence of the fever warrants a visit to the health
facility, since this is more likely to be attributable to other
causes than malaria. Unfortunately, no data were col-
lected to document the possible indications for referral.
The feasibility and acceptability of the use of ACTs within
the context of HMM has been demonstrated by Ajayi et al
[13], in a multi-centre study involving four African sites.
The present study confirms this finding, as reflected by the
high proportion of malaria cases treated by CHWs/KOLs
in the intervention arm. The level of knowledge of the
CHWs/KOLs of the common clinical symptoms of
malaria, and the accuracy in the prescription of study drug
was appreciable at the post training survey. There is, there-
fore, a potential for well-trained CHWs/KOLs to increase
the access of the population to appropriate treatment for
malaria.
One of the concerns about the wide-scale use of ACTs by
the CHWs/KOLs is the possibility of over-prescription of
the drug, leading to wastage and possibly increasing the
risk of emergence of resistance [12,15,16]. This cannot be
excluded in this study. The use of rapid diagnosis tests to
target the treatment of true malaria cases with the ACTs is
one of the solutions being explored. It has the potential of
adding great value to the CHWs/KOLs current perform-
ance in managing malaria close to the home, by avoiding
the unnecessary delay in the treatment of non-malaria ill-
ness, which could be observed with the current presump-
tive treatment strategy.
The increase in the number of malaria cases treated at the
community level is associated with a reduction of the
overall workload at health facility level. In the study, the
HF attendance rate was lowered by 43% in the interven-
tion arm, with most malaria cases being treated in the
community. In the breakdown of disease episodes treated
Number of diseases episodes (all causes) and malaria epi- sodes treated at the health facility level Figure 2
Number of diseases episodes (all causes) and malaria 
episodes treated at the health facility level.Malaria Journal 2008, 7:201 http://www.malariajournal.com/content/7/1/201
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at HF level, malaria accounts for 21% of all attendances in
the HF of the intervention arm, while it represents 70.7%
in the HF of the control arm. The implications of this find-
ing are obvious.
In developing countries, where malaria burden poses a
challenge to the health system, the first level of care for the
sick patients is the one that usually bears the high burden
of the disease. In this study, the CSPS represents the first
point of contact of sick children with the health system,
and the workload imposed by the treatment of malaria
cases in children by health personnel is not negligible. The
intervention has demonstrated the potential of reducing
this burden by at least 70.0%.
The health workforce shortage crisis in developing coun-
tries is one of the major challenges the health system is
facing; it is estimated that to achieve even a modest cover-
age for essential health interventions, the health worker
density required is 2.28 per 1,000 population[17]; in the
context of the study area, the actual rates were respectively
one nurse per 3,700 population and one doctor per
30,000 [18]. Shortages of health workers in sub-Saharan
Africa derive from many causes; among others, one could
include past investment shortfalls in pre-service training,
morbidity and premature mortality, international migra-
tion, premature retirement [19,20].
While various solutions are being explored by policy-
makers to circumvent this problem, an intervention
reducing by 70% the workload imposed by the treatment
of malaria cases in children, could be seen as intermediate
solution for malaria endemic countries. Indeed, in the
context of limited workforce, the precious time saved
could be used by the health staff, for other curative or pre-
ventive activities, or to allow a longer nurse-patient con-
tact time, a factor known to be associated with correct
management of patients, and higher adherence by car-
egivers [21].
The home-management of other diseases, such as pneu-
monia and diarrhoea, is being investigated [22]. There is
no doubt that if this could be achieved successfully, as
what was observed for malaria, this might contribute to
the Millennium Development Goal of reducing children
mortality with the increase of the prompt access to appro-
priate treatment.
Conclusion
This study has shown that well-trained CHWs/KOLs could
provide appropriate treatment for the majority of child-
hood malaria episodes in their respective communities,
and thereby reduce the workload of health staff operating
at HF level. This finding provides evidence that a scaling-
up of the HMM strategy might contribute to minimize the
consequences of workforce shortage at peripheral health
facilities level in most of the malaria endemic countries,
and possibly improve their performance.
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